Doctor Marion Dahlke
Basel (Switzerland)
Characterisation of serelaxin pharmacokinetics using a population pharmacokinetics approach
Event: HEART FAILURE 2016
Topic: Acute heart failure (management)
Session: Acute heart failure
ESC 365 is supported by
